PANDA Therapeutics is developing an antibody-based treatment designed to tackle multiple harmful protein deposits in the brain simultaneously.
PANDA Therapeutics has raised €160k across 1 funding round from 1 investor, most recently a round in Aug 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 1 Sept 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-08-31 | Other |
| €160k |
| Venture Kick |
| View deal → |
